Diabetic ketoacidosis at diagnosis among youth with type 1 and type 2 diabetes: Results from SEARCH (United States) and YDR (India) registries.


Journal

Pediatric diabetes
ISSN: 1399-5448
Titre abrégé: Pediatr Diabetes
Pays: Denmark
ID NLM: 100939345

Informations de publication

Date de publication:
02 2021
Historique:
received: 10 06 2019
revised: 12 12 2019
accepted: 09 01 2020
pubmed: 17 1 2020
medline: 18 11 2021
entrez: 17 1 2020
Statut: ppublish

Résumé

There is significant global variation in the prevalence of diabetic ketoacidosis (DKA) at diagnosis among youth with type 1 diabetes (T1D). However, data for youth with type 2 diabetes (T2D) are limited, even in developed countries. We compared the prevalence of DKA at diagnosis among individuals with T1D and T2D from the SEARCH for Diabetes in Youth (SEARCH) and the Registry of Youth Onset Diabetes in India (YDR) registries. We harmonized the SEARCH and YDR registries to the structure and terminology in the Observational Medical Outcome Partnership Common Data Model. Data used were from youth with T1D and T2D diagnosed before 20 years and newly diagnosed between 2006 and 2012 in YDR and 2009 and 2012 in SEARCH. There were 5366 US youth (4078 with T1D, 1288 with T2D) and 2335 Indian youth (2108 with T1D, 227 with T2D). More than one third of T1D youth enrolled in SEARCH had DKA at diagnosis which was significantly higher than in YDR (35.3% vs 28.7%, P < .0001). The burden of DKA in youth with T1D was significantly higher among younger age groups; this relationship was similar across registries (P = .4). The prevalence of DKA among T2D in SEARCH and YDR were 5.5% and 6.6% respectively (P = .4). There is significant burden of DKA at diagnosis with T1D among youth from United States and India, especially among the younger age groups. The reasons for this high prevalence are largely unknown but are critical to developing interventions to prevent DKA at diagnosis.

Sections du résumé

BACKGROUND
There is significant global variation in the prevalence of diabetic ketoacidosis (DKA) at diagnosis among youth with type 1 diabetes (T1D). However, data for youth with type 2 diabetes (T2D) are limited, even in developed countries. We compared the prevalence of DKA at diagnosis among individuals with T1D and T2D from the SEARCH for Diabetes in Youth (SEARCH) and the Registry of Youth Onset Diabetes in India (YDR) registries.
METHODS
We harmonized the SEARCH and YDR registries to the structure and terminology in the Observational Medical Outcome Partnership Common Data Model. Data used were from youth with T1D and T2D diagnosed before 20 years and newly diagnosed between 2006 and 2012 in YDR and 2009 and 2012 in SEARCH.
RESULTS
There were 5366 US youth (4078 with T1D, 1288 with T2D) and 2335 Indian youth (2108 with T1D, 227 with T2D). More than one third of T1D youth enrolled in SEARCH had DKA at diagnosis which was significantly higher than in YDR (35.3% vs 28.7%, P < .0001). The burden of DKA in youth with T1D was significantly higher among younger age groups; this relationship was similar across registries (P = .4). The prevalence of DKA among T2D in SEARCH and YDR were 5.5% and 6.6% respectively (P = .4).
CONCLUSIONS
There is significant burden of DKA at diagnosis with T1D among youth from United States and India, especially among the younger age groups. The reasons for this high prevalence are largely unknown but are critical to developing interventions to prevent DKA at diagnosis.

Identifiants

pubmed: 31943641
doi: 10.1111/pedi.12979
pmc: PMC7748377
mid: NIHMS1648755
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

40-46

Subventions

Organisme : NIDDK NIH HHS
ID : P30 DK057516
Pays : United States
Organisme : ACL HHS
ID : U18DP006139
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U01 DP000247
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000154
Pays : United States
Organisme : CDC HHS
ID : U48/CCU819241-3
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U01 DP000244
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000062
Pays : United States
Organisme : ACL HHS
ID : U18DP006134
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U18 DP002709
Pays : United States
Organisme : CDC HHS
ID : U18DP002708
Pays : United States
Organisme : NIH HHS
ID : R21DK105869-02
Pays : United States
Organisme : CDC HHS
ID : U18DP006138
Pays : United States
Organisme : CDC HHS
ID : U48/CCU519239
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U18 DP002710
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR00423
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U18 DP006138
Pays : United States
Organisme : NIH HHS
ID : P30 DK57516
Pays : United States
Organisme : CDC HHS
ID : U48/CCU919219
Pays : United States
Organisme : ACL HHS
ID : U18DP006138
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U18 DP002714
Pays : United States
Organisme : CDC HHS
ID : U18DP006134
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 Tr001450
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U01 DP000248
Pays : United States
Organisme : CDC HHS
ID : 00097
Pays : United States
Organisme : CDC HHS
ID : U18DP002714
Pays : United States
Organisme : CDC HHS
ID : U48/CCU419249
Pays : United States
Organisme : CDC HHS
ID : 1U18DP002709
Pays : United States
Organisme : CDC HHS
ID : U58/CCU019235-4
Pays : United States
Organisme : CDC HHS
ID : U18DP002710-01
Pays : United States
Organisme : CDC HHS
ID : U18DP006136
Pays : United States
Organisme : ACL HHS
ID : U18DP006131
Pays : United States
Organisme : CDC HHS
ID : DP-10-001
Pays : United States
Organisme : NIDDK NIH HHS
ID : R21 DK105869
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001425
Pays : United States
Organisme : CDC HHS
ID : U18DP006139
Pays : United States
Organisme : CDC HHS
ID : 200-2010-35171
Pays : United States
Organisme : CDC HHS
ID : U18DP006133
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000077
Pays : United States
Organisme : CDC HHS
ID : DP-05-069
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK127208
Pays : United States
Organisme : CDC HHS
ID : 1U18DP006131
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000423
Pays : United States
Organisme : ACL HHS
ID : U18DP006136
Pays : United States
Organisme : CDC HHS
ID : U18DP000247-06A1
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U01 DP000250
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U01 DP000246
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U01 DP000254
Pays : United States
Organisme : ACL HHS
ID : U18DP006133
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U18 DP002708
Pays : United States

Informations de copyright

© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Pediatrics. 2014 Apr;133(4):e938-45
pubmed: 24685959
Diabetologia. 2012 Nov;55(11):2878-94
pubmed: 22933123
Pediatr Diabetes. 2010 Aug;11(5):351-6
pubmed: 19821943
J Pediatr. 2005 May;146(5):688-92
pubmed: 15870676
Ann N Y Acad Sci. 2008 Dec;1150:1-13
pubmed: 19120261
Arch Dis Child. 2001 Jul;85(1):16-22
pubmed: 11420189
Diabetes Care. 2017 Sep;40(9):1249-1255
pubmed: 28667128
J Diabetes Sci Technol. 2016 Aug 22;10(5):1034-41
pubmed: 27179010
Pediatr Diabetes. 2002 Jun;3(2):82-8
pubmed: 15016161
World J Diabetes. 2014 Dec 15;5(6):932-8
pubmed: 25512799
Diabetes Care. 2018 Dec;41(12):2648-2668
pubmed: 30425094
Sci Rep. 2015 May 19;5:10358
pubmed: 25989414
J Diabetes Complications. 2018 Jul;32(7):650-654
pubmed: 29903409
Am J Med Sci. 2006 May;331(5):243-51
pubmed: 16702793
Pediatr Diabetes. 2019 Mar;20(2):172-179
pubmed: 30556249
Diabetes Care. 2014 Dec;37(12):3336-44
pubmed: 25414389
N Engl J Med. 2001 Jan 25;344(4):264-9
pubmed: 11172153
Diabetologia. 2001 Oct;44 Suppl 3:B75-80
pubmed: 11724421
Diabetes Care. 2007 Apr;30(4):861-6
pubmed: 17392547
Pediatr Diabetes. 2018 Mar;19(2):320-328
pubmed: 28568379

Auteurs

Pradeep A Praveen (PA)

Department of Endocrinology and Metabolism, All India Institute of Medical Sciences, New Delhi, India.

Christine W Hockett (CW)

Lifecourse Epidemiology of Adiposity and Diabetes Center, Colorado School of Public Health, University of Colorado Denver, Aurora, Colorado.

Toan C Ong (TC)

Department of Pediatrics, University of Colorado, Aurora, Colorado.

Anandakumar Amutha (A)

Dr. Mohan's Diabetes Specialties Centre and Madras Diabetes Research Foundation, Chennai, India.

Scott P Isom (SP)

Department of Biostatistics and Bioinformatics, Wake Forest School of Medicine, Winston-Salem, North Carolina.

Elizabeth T Jensen (ET)

Department of Epidemiology, Wake Forest School of Medicine, Winston-Salem, North Carolina.

Viswanathan Mohan (V)

Dr. Mohan's Diabetes Specialties Centre and Madras Diabetes Research Foundation, Chennai, India.

Dana A Dabelea (DA)

Lifecourse Epidemiology of Adiposity and Diabetes Center, Colorado School of Public Health, University of Colorado Denver, Aurora, Colorado.

Ralph B D'Agostino (RB)

Department of Biostatistics and Bioinformatics, Wake Forest School of Medicine, Winston-Salem, North Carolina.

Richard F Hamman (RF)

Lifecourse Epidemiology of Adiposity and Diabetes Center, Colorado School of Public Health, University of Colorado Denver, Aurora, Colorado.

Elizabeth J Mayer-Davis (EJ)

Department of Nutrition, University of North Carolina, Chapel Hill, North Carolina.

Jean M Lawrence (JM)

Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California.

Lawrence M Dolan (LM)

Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio.

Michael G Kahn (MG)

Department of Pediatrics, University of Colorado, Aurora, Colorado.

Sri Venkata Madhu (SV)

University College of Medical Science, GTB Hospital, Delhi, India.

Nikhil Tandon (N)

Department of Endocrinology and Metabolism, All India Institute of Medical Sciences, New Delhi, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH